Beta-glucan for Pneumocystis pneumonia diagnosis in persons with AIDS: authors' reply

Affiliations

¹ aDivision of Allergy and Infectious Disease, University of Washington, Seattle, Washington bHarvard School of Public Health, Boston, Massachusetts cDivision of Infectious Diseases and Department of Medicine, Stanford University School of Medicine, Stanford, California dAssociates of Cape Cod, East Falmouth, Massachusetts eDivision of Infectious Diseases, Washington University, St. Louis, Missouri fDivision of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Comment

Brian R Wood et al. AIDS. 2013.

. 2013 Nov 28;27(18):2967-8.

doi: 10.1097/QAD.0000000000000018.

¹ aDivision of Allergy and Infectious Disease, University of Washington, Seattle, Washington bHarvard School of Public Health, Boston, Massachusetts cDivision of Infectious Diseases and Department of Medicine, Stanford University School of Medicine, Stanford, California dAssociates of Cape Cod, East Falmouth, Massachusetts eDivision of Infectious Diseases, Washington University, St. Louis, Missouri fDivision of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Comment on

Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.
Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE. Wood BR, et al. AIDS. 2013 Mar 27;27(6):967-972. doi: 10.1097/QAD.0b013e32835cb646. AIDS. 2013. PMID: 23698062 Free PMC article.
Test performance of beta-glucan for Pneumocystis jirovecii pneumonia put in a clinical context.
Boyles TH. Boyles TH. AIDS. 2013 Jun 19;27(10):1679. doi: 10.1097/QAD.0b013e3283620831. AIDS. 2013. PMID: 24047766 No abstract available.